BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 2178884)

  • 1. Cisplatin nephrotoxicity: experimental and clinical studies.
    Daugaard G
    Dan Med Bull; 1990 Feb; 37(1):1-12. PubMed ID: 2178884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.
    Hartmann JT; Fels LM; Franzke A; Knop S; Renn M; Maess B; Panagiotou P; Lampe H; Kanz L; Stolte H; Bokemeyer C
    Anticancer Res; 2000; 20(5C):3767-73. PubMed ID: 11268452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin nephrotoxicity and protection by silibinin.
    Gaedeke J; Fels LM; Bokemeyer C; Mengs U; Stolte H; Lentzen H
    Nephrol Dial Transplant; 1996 Jan; 11(1):55-62. PubMed ID: 8649653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of cisplatin nephrotoxicity.
    Weiner MW; Jacobs C
    Fed Proc; 1983 Oct; 42(13):2974-8. PubMed ID: 6684595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Definitive end-stage chronic kidney failure after cisplatin treatment].
    Brillet G; Deray G; Lucsko M; Faucher C; Aubert P; Rottembourg J; Jacobs C
    Nephrologie; 1993; 14(5):227-9. PubMed ID: 8159252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canine and human renal toxicity of inosine dialdehyde (NSC 118994).
    Kaufman J; Keogh B; Mittelman A; Wallens T; Murphy GP
    J Med; 1977; 8(3-4):239-51. PubMed ID: 267714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical investigation of cis-platinum nephrotoxicity in 244 cases of primary lung cancer].
    Soejima A; Inoue T; Suzuki M; Waku M; Nakabayashi K; Kitamoto K; Nagasawa T
    Nihon Jinzo Gakkai Shi; 1992 Jul; 34(7):801-6. PubMed ID: 1479719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of combination chemotherapy with cis-diamminedichloroplatinum (II) (CDDP) on renal function in patients with urogenital malignancies].
    Kawamura J; Hida S; Higashi Y; Yamauchi T; Soeda A; Yoshida O
    Hinyokika Kiyo; 1985 Feb; 31(2):207-21. PubMed ID: 4040315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cis-diamminedichloroplatinum (II)-induced acute renal failure in the rat. Correlation of structural and functional alterations.
    Jones TW; Chopra S; Kaufman JS; Flamenbaum W; Trump BF
    Lab Invest; 1985 Apr; 52(4):363-74. PubMed ID: 4039014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is permanent renal function damage possible after hemorrhagic fever with renal syndrome?].
    Ledina D; Bradarić N; Ivić I; Marasović D; Radović D; Ostojić-Bakotin V; Prgomet S
    Acta Med Croatica; 2003; 57(5):365-8. PubMed ID: 15011462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible mechanisms for N-acetyl cysteine and taurine in ameliorating acute renal failure induced by cisplatin in rats.
    Shalby AB; Assaf N; Ahmed HH
    Toxicol Mech Methods; 2011 Sep; 21(7):538-46. PubMed ID: 21470069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ifosfamide-induced nephrotoxicity].
    Rossi R; Rath B; Ullrich K; Ehrich JH
    Monatsschr Kinderheilkd; 1993 Jul; 141(7):594-601. PubMed ID: 8413339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrotoxicity of lysine and of a single dose of aminoglycoside in rats given lysine.
    Malis CD; Racusen LC; Solez K; Whelton A
    J Lab Clin Med; 1984 May; 103(5):660-76. PubMed ID: 6425441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on the mechanisms of renal damages induced by nephrotoxic compounds].
    Yamada T
    Nihon Hoigaku Zasshi; 1995 Dec; 49(6):447-57. PubMed ID: 8583688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway.
    Wainford RD; Weaver RJ; Stewart KN; Brown P; Hawksworth GM
    Toxicology; 2008 Jul; 249(2-3):184-93. PubMed ID: 18583013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical multivariate statistical analysis of nephrotoxicity induced by cisplatin].
    Ding DC
    Zhonghua Zhong Liu Za Zhi; 1992 Jan; 14(1):64-6. PubMed ID: 1396050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicology and Carcinogenesis Studies of Ochratoxin A (CAS No. 303-47-9) in F344/N Rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1989 May; 358():1-142. PubMed ID: 12695783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity.
    Sánchez-González PD; López-Hernández FJ; López-Novoa JM; Morales AI
    Crit Rev Toxicol; 2011 Nov; 41(10):803-21. PubMed ID: 21838551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cisplatin on renal function in rabbits: mechanism of reduced glucose reabsorption.
    Kim YK; Byun HS; Kim YH; Woo JS; Lee SH
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):19-26. PubMed ID: 7839366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.